Skip to main content
Commonwealth of Virginia branding bar cardinal logo

Virginia.gov

A design prototype by Datopian, not an official website

Find a Commonwealth Resource
Virginia Open Data

Larotrectinib

HealthData.Gov

Updated Oct 29, 2026

About this dataset

Vitrakvi (larotrectinib) is an oral solution that inhibits tropomyosin receptor kinases, prescribed for certain cancers with NTRK gene fusions. It's a 20 mg/mL concentrate manufactured by Bayer HealthCare Pharmaceuticals Inc. and approved under NDA211710 in December 2022. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Larotrectinib

    Access the FDA dataset for Larotrectinib — ANDA 211710 submitted by Mylan Institutional LLC

    Modified Jul 29, 2026

    Open link: Larotrectinib
Prototype by Datopian · not an official government website · data from data.virginia.gov